Cargando…
Immunogenicity of a reduced dose of A/H3N2 in the 2005 southern hemisphere formulation of inactivated split influenza vaccine
Background The 2005 southern hemisphere formulation of the inactivated split‐virion influenza vaccine Vaxigrip(®) unintentionally contained a lower concentration of haemagglutinin (HA) than European Pharmacopoeia (EP) and WHO specifications for one of the three strains. Objectives To evaluate the...
Autores principales: | Burrell, Christopher, Booy, Robert, Wood, Nicholas, Egan, Anne‐Marie, Taverner, David, Williams, Ken, Liauw, Winston, Moskwa, Alan, Pepin‐Covatta, Stephanie, Saville, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634696/ https://www.ncbi.nlm.nih.gov/pubmed/19453468 http://dx.doi.org/10.1111/j.1750-2659.2008.00039.x |
Ejemplares similares
-
Immunogenicity and safety of the 2015 Southern Hemisphere formulation of a split-virion inactivated quadrivalent vaccine
por: Montalban, Cecilia, et al.
Publicado: (2017) -
Immunogenicity and safety of the Southern Hemisphere 2015 formulation of Vaxigrip®
por: Latreille-Barbier, Mathilde, et al.
Publicado: (2017) -
Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil
por: Zerbini, Cristiano A.F., et al.
Publicado: (2016) -
Analysis of Viral and Host Factors on Immunogenicity of 2018, 2019, and 2020 Southern Hemisphere Seasonal Trivalent Inactivated Influenza Vaccine in Adults in Brazil
por: Capão, Artur, et al.
Publicado: (2022) -
Cross‐neutralisation of antibodies elicited by an inactivated split‐virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains
por: Höschler, Katja, et al.
Publicado: (2008)